Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_2
4
27%
Ph not_applicable
3
20%
Ph phase_1
3
20%
Ph phase_3
4
27%
Ph phase_4
1
7%

Phase Distribution

3

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
3(20.0%)
Phase 2Efficacy & side effects
4(26.7%)
Phase 3Large-scale testing
4(26.7%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
3(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(12)
Terminated(2)
Other(1)

Detailed Status

Completed12
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (20.0%)
Phase 24 (26.7%)
Phase 34 (26.7%)
Phase 41 (6.7%)
N/A3 (20.0%)

Trials by Status

unknown17%
completed1280%
terminated213%

Recent Activity

0 active trials
Showing 5 of 15
completedphase_3

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

NCT00131703
completedphase_3

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

NCT03208179
completedphase_3

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

NCT01746199
unknownphase_1

Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine

NCT03599596
completedphase_1

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

NCT02527005
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT00131703Phase 3

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

Completed
NCT03208179Phase 3

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

Completed
NCT01746199Phase 3

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

Completed
NCT03599596Phase 1

Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine

Unknown
NCT02527005Phase 1

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

Completed
NCT02524444Phase 1

A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients

Completed
NCT00361114Phase 3

IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.

Terminated
NCT00158574Phase 2

Kilimanjaro IPTi Drug Options Trial

Completed
NCT00146783Phase 2

Navrongo Drug Options for IPT in Pregnancy Trial

Completed
NCT00119132Phase 2

Effectiveness of Intermittent Preventive Treatment for Malaria in Children

Completed
NCT00140517Not Applicable

Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance

Completed
NCT02831023Phase 2

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Completed
NCT00811421Not Applicable

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

Completed
NCT00964691Phase 4

A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands

Terminated
NCT00301054Not Applicable

Study on Preventing Anemia in Children in Ghana

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15